Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
- PMID: 34697839
- DOI: 10.1002/ptr.7305
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Abstract
Curcumin is a phytochemical isolated from Curcuma longa with potent tumor-suppressor activity, which has shown significant efficacy in pre-clinical and clinical studies. Curcumin stimulates cell death, triggers cycle arrest, and suppresses oncogenic pathways, thereby suppressing cancer progression. Cisplatin (CP) stimulates DNA damage and apoptosis in cancer chemotherapy. However, CP has adverse effects on several organs of the body, and drug resistance is frequently observed. The purpose of the present review is to show the function of curcumin in decreasing CP's adverse impacts and improving its antitumor activity. Curcumin administration reduces ROS levels to prevent apoptosis in normal cells. Furthermore, curcumin can inhibit inflammation via down-regulation of NF-κB to maintain the normal function of organs. Curcumin and its nanoformulations can reduce the hepatoxicity, neurotoxicity, renal toxicity, ototoxicity, and cardiotoxicity caused by CP. Notably, curcumin potentiates CP cytotoxicity via mediating cell death and cycle arrest. Besides, curcumin suppresses the STAT3 and NF-ĸB as tumor-promoting pathways, to enhance CP sensitivity and prevent drug resistance. The targeted delivery of curcumin and CP to tumor cells can be mediated nanostructures. In addition, curcumin derivatives are also able to reduce CP-mediated side effects, and increase CP cytotoxicity against various cancer types.
Keywords: apoptosis; chemoresistance; cisplatin; combination cancer chemotherapy; curcumin; side effects.
© 2021 John Wiley & Sons Ltd.
References
REFERENCES
-
- Abd El-Kader, M., & Taha, R. I. (2020). Comparative nephroprotective effects of curcumin and etoricoxib against cisplatin-induced acute kidney injury in rats. Acta Histochemica, 122(4), 151534.
-
- Abd Rashid, N., Hussan, F., Hamid, A., Adib Ridzuan, N. R., Halim, S., Abdul Jalil, N. A., … Budin, S. B. (2020). Polygonum minus essential oil modulates cisplatin-induced hepatotoxicity through inflammatory and apoptotic pathways. EXCLI Journal, 19, 1246-1265.
-
- Abegg, D., Frei, R., Cerato, L., Prasad Hari, D., Wang, C., Waser, J., & Adibekian, A. (2015). Proteome-wide profiling of targets of cysteine reactive small molecules by using ethynyl benziodoxolone reagents. Angewandte Chemie (International Ed. in English), 54(37), 10852-10857.
-
- Abuzeid, W. M., Davis, S., Tang, A. L., Saunders, L., Brenner, J. C., Lin, J., … Carey, T. E. (2011). Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog. Archives of Otolaryngology - Head & Neck Surgery, 137(5), 499-507.
-
- Agthong, S., Kaewsema, A., & Charoensub, T. (2015). Curcumin ameliorates functional and structural abnormalities in cisplatin-induced neuropathy. Experimental Neurobiology, 24(2), 139-145.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
